The U.S. Food and Drug Administration has reviewed 20 laboratory developed tests (LDTs) used to diagnose serious medical conditions, including cancer and heart disease, and found the products may be causing or are causing significant harm to patients.

The FDA has not actively regulated LDTs in the past, but the agency hinted that its stance may be changing.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access